Related Experiment Video
Updated: Jul 23, 2025

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Pharmacological Activity of Cepharanthine
Ke Liu1, Bixia Hong1, Shuqi Wang1
1College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Cepharanthine, a plant-derived alkaloid, shows broad medicinal benefits, including significant antiviral activity against SARS-CoV-2. Its mechanism may involve stabilizing plasma membrane fluidity, highlighting its potential for diverse therapeutic applications.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Virology
Background:
- Cepharanthine is a bisbenzylisoquinoline alkaloid from *Stephania Cephalantha Hayata*.
- It is the only approved bisbenzylisoquinoline alkaloid for human use, with over 70 years of clinical application.
- Cepharanthine exhibits diverse medicinal properties, including immunomodulatory and antiviral activities.
Purpose of the Study:
- To comprehensively review the pharmacological properties and mechanisms of cepharanthine.
- To investigate its potential as an antiviral agent, particularly against SARS-CoV-2.
- To discuss its safety, bioavailability, and future clinical applications.
Main Methods:
- Literature review of pharmacological studies on cepharanthine.
- Analysis of reported mechanisms of action, including signaling pathway inhibition.
- Examination of clinical data regarding safety and efficacy.
Main Results:
- Cepharanthine demonstrates antitumor, anti-inflammatory, anti-pathogen, and bone resorption inhibitory effects.
- It has shown efficacy in treating alopecia and snake bites.
- A key antiviral mechanism identified is the stabilization of plasma membrane fluidity.
Conclusions:
- Cepharanthine possesses a wide range of pharmacological activities and a favorable safety profile.
- Its potential to inhibit SARS-CoV-2 infection is significant.
- Cepharanthine holds promise for various clinical applications and future drug development.
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Direct-Acting Cholinergic Agonists: Therapeutic Uses

